<DOC>
	<DOCNO>NCT02911701</DOCNO>
	<brief_summary>NSAIDs , specifically cyclo-oxygenase ( COX ) inhibitor , know increase blood pressure time non-pregnant adult , effect COX-inhibitors blood pressure set preeclampsia well study . This study aim assess effect avoid COX-inhibitors postpartum blood pressure control among woman diagnose preeclampsia severe feature . Eligible woman randomize receive either acetaminophen ibuprofen postpartum pain control . Both agent first line therapy pain control although ibuprofen good pain control acetaminophen . The primary outcome duration postpartum severe-range hypertension .</brief_summary>
	<brief_title>Effect Acetaminophen Postpartum Blood Pressure Control Preeclampsia With Severe Features</brief_title>
	<detailed_description>The propose study randomize , control , double-masked trial compare effect postpartum acetaminophen ibuprofen blood pressure among woman preeclampsia . Study participant randomize receive either acetaminophen ibuprofen mild postpartum pain control . Study participant , study personnel provider blind randomization status study participant . Potential study participant enrol diagnose severe hypertensive disorder pregnancy . This usually occur prior delivery , may occur 6 hour delivery . Patients diagnose preeclampsia without severe feature also approach enrolled time diagnosis anticipation possible progression preeclampsia severe feature . Once enrol , study participant randomize delivery , time randomize receive either acetaminophen ibuprofen mild postpartum pain . Both group available oxycodone moderate severe pain , per routine . Study group allocation know investigational pharmacy . The ibuprofen acetaminophen make appear identical unmarked encapsulation . Block randomization use ensure equal allocation two study arm . For duration study participation , study participant undergo postpartum monitoring vital sign measurement ( include blood pressure ) every 4 hour , pain assessment administration study medication , well daily evaluation laboratory study normalize satisfaction provider . Study participant receive study drug every 6 hour time delivery hospital discharge , unless refuse . Study participation complete upon hospital discharge . Study participant contact study team member 6 week delivery ask additional complication symptom require visit emergency department hospital readmission . Descriptive factor clinical outcome extract medical record de-identified study personnel day study participation .</detailed_description>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Eclampsia</mesh_term>
	<mesh_term>HELLP Syndrome</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>ability give inform consent diagnosis `` severe '' hypertensive disorder pregnancy : preeclampsia severe feature chronic hypertension superimpose preeclampsia severe feature HELLP syndrome : hemolysis , elevate liver function test , low platelet eclampsia yet deliver less 6 hour delivery current incarceration serum creatinine &gt; 1.0 mg/dL suspicion acute kidney injury AST ( aspartate aminotransferase ) &gt; 200 unit/L ALT ( alanine aminotransferase ) &gt; 200 unit/L know allergy sensitivity NSAIDs acetaminophen delivery &gt; 6 hour prior enrollment chronic kidney disease chronic liver disease prior liver transplant chronic infectious hepatitis gastritis gastroesophageal reflux disease ( GERD ) peptic ulcer disease bleed disorder provider feel participation best interest patient</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>